n/a
Abstract Title:

Effectiveness of the piperine-supplementedL. in metabolic control of patients with type 2 diabetes: a randomised double-blind placebo-controlled clinical trial.

Abstract Source:

Int J Food Sci Nutr. 2021 Feb 14:1-10. Epub 2021 Feb 14. PMID: 33586583

Abstract Author(s):

Joana Furtado de Figueiredo Neta, Vivian Saraiva Veras, Danilo Ferreira de Sousa, Maria da Conceição Dos Santos Oliveira Cunha, Maria Veraci Oliveira Queiroz, José Claudio Garcia Lira Neto, Marta Maria Coelho Damasceno, Márcio Flávio Moura de Araújo, Roberto Wagner Júnior Freire de Freitas

Article Affiliation:

Joana Furtado de Figueiredo Neta

Abstract:

There is robust evidence of usingL. in reducing metabolic levels in people with diabetes. This study analysed the effectiveness ofL. in the metabolic control of patients with type 2 diabetes in Brazil. A randomised double-blind placebo-controlled clinical trial was conducted with 71 participants divided into aL. group (500 mg/day with piperine 5 mg) and a placebo group, for 120 days. Anthropometric, clinical and biochemical variables were evaluated at baseline, 60 and 120 days after the beginning of the intervention. Paired and independent Student's-test and chi-square test were used for statistical analysis. The curcuma group presented a significantly decreased glycaemia (=.013), glycated haemoglobin (=.015), HOMA index (=.037) and triglycerides (TGs) (=.002). The use of piperine-addedL. was effective in the glycaemic and TG control of patients with type 2 diabetes.

Study Type : Human Study

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.